Static Chart BeOne Medicines AG

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2026 am IST			5-day change	1st Jan Change
317.00 ^USD	+1.17%		+7.36%	+4.34%

29/04	BeOne Medicines Receives US FDA Priority Review for Tevimbra Combination Therapy	MT
29/04	BeOne Medicines Ltd. Receives Priority Review For Tevimbra In Combination With Ziihera And Chemotherapy For First-Line Her2-Positive Gastroesophageal Adenocarcinoma	CI

Duration

Period